{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:50:38Z","timestamp":1794585038069,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Program of the Educational Commission of Anhui Province","award":["2023AH053313"],"award-info":[{"award-number":["2023AH053313"]}]},{"name":"the Health Research Program of Anhui Province","award":["AHWJ2023A30055"],"award-info":[{"award-number":["AHWJ2023A30055"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372646"],"award-info":[{"award-number":["82372646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Identifying potential molecular targets for GC liver metastasis (GCLM) may provide new treatment avenues. Initially, using label-free proteomics to screen clinical samples from GCLM patients suggested ASF1B as a possible promoter of GCLM. We further validated this finding with in vitro experiments and spleen injection liver metastasis model, subsequent transcriptome sequencing after ASF1B knockdown revealed SLC7A11-mediated ferroptosis is critical for GCLM progression. Mechanistically, ASF1B recruits and binds to the transcription factor HOXB3, thereby promoting ZDHHC9\u2019s transcriptional level. Additionally, ZDHHC9 regulates SLC7A11-mediated ferroptosis in GC cells. Further tumor metastasis assays showed ZDHHC9 promotes peritoneal, pulmonary, and hepatic metastases in GC. Subsequently, immunoprecipitation and LC-MS analyses revealed the molecular interaction between ZDHHC9 and PCBP1. ZDHHC9, a palmitoyltransferase, inhibits ferroptosis by palmitoylating PCBP1. Mechanistically, ZDHHC9 palmitoylates PCBP1 at residue C109, inhibiting PCBP1 ubiquitination and thereby suppressing SLC7A11-mediated ferroptosis. In line with this, further experiments showed PCBP1 regulates ferroptosis by modulating SLC7A11 RNA stability. Finally, IHC and immunofluorescence revealed significant clinical correlations among ASF1B, ZDHHC9, PCBP1, and SLC7A11. Additionally, this signaling axis is strongly associated with PD-L1 expression. In conclusion, this study demonstrates ASF1B promotes GC liver metastasis by inhibiting ferroptosis via the ZDHHC9\/PCBP1\/SLC7A11 axis, providing a potential immunotherapeutic target for GCLM.<\/jats:p>","DOI":"10.1038\/s41698-026-01272-w","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:15:26Z","timestamp":1768371326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["ASF1B promotes gastric cancer liver metastasis through inhibiting ZDHHC9\/PCBP1\/ SLC7A11 signaling axis mediated ferroptosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Mingliang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA-Cancer J. Clin."},{"key":"1272_CR2","doi-asserted-by":"publisher","first-page":"e0299421","DOI":"10.1128\/mBio.02994-21","volume":"12","author":"D Yu","year":"2021","unstructured":"Yu, D. et al. Fecal Streptococcus alteration is associated with gastric cancer occurrence and liver metastasis. mBio 12, e0299421 (2021).","journal-title":"mBio"},{"key":"1272_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","volume":"157","author":"C Huang","year":"2022","unstructured":"Huang, C. et al. Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg. 157, 9\u201317 (2022).","journal-title":"JAMA Surg."},{"key":"1272_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2017.10.011","volume":"412","author":"K Das","year":"2018","unstructured":"Das, K. et al. Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301\/TOP002 phase III clinical trial. Cancer Lett. 412, 208\u2013215 (2018).","journal-title":"Cancer Lett."},{"key":"1272_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","volume":"17","author":"K Fujitani","year":"2016","unstructured":"Fujitani, K. et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 17, 309\u2013318 (2016).","journal-title":"Lancet Oncol."},{"key":"1272_CR6","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2967\/jnumed.120.249300","volume":"62","author":"H Li","year":"2021","unstructured":"Li, H. et al. Utility of At-trastuzumab for the treatment of metastatic gastric cancer in the liver: evaluation of a preclinical \u03b1-radioimmunotherapy approach in a clinically relevant mouse model. J. Nucl. Med. 62, 1468\u20131474 (2021).","journal-title":"J. Nucl. Med."},{"key":"1272_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. METTL3-mediated mA modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69, 1193\u20131205 (2020).","journal-title":"Gut"},{"key":"1272_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41388-022-02537-x","volume":"42","author":"D Li","year":"2023","unstructured":"Li, D. et al. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene 42, 83\u201398 (2023).","journal-title":"Oncogene"},{"key":"1272_CR9","doi-asserted-by":"crossref","unstructured":"Wei, F. et al. SZDHHC7-mediated palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. Autophagy 20, 2719\u20132737 (2024).","DOI":"10.1080\/15548627.2024.2386915"},{"key":"1272_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.gastro.2024.04.009","volume":"167","author":"C Tran","year":"2024","unstructured":"Tran, C. et al. Phosphatidylinositol 4-kinase III \u03b1 governs cytoskeletal organization for invasiveness of liver cancer cells. Gastroenterology 167, 522\u2013537 (2024).","journal-title":"Gastroenterology"},{"key":"1272_CR11","first-page":"1","volume":"17","author":"Z Binhui","year":"2022","unstructured":"Binhui, Z. et al. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol. Oncol. 17, 1 (2022).","journal-title":"Mol. Oncol."},{"key":"1272_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-024-07373-5","volume":"630","author":"G Du","year":"2024","unstructured":"Du, G. et al. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature 630, 437\u2013446 (2024).","journal-title":"Nature"},{"key":"1272_CR13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s11427-021-2048-2","volume":"65","author":"X Pei","year":"2022","unstructured":"Pei, X. et al. Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth. Sci. China Life Sci. 65, 2017\u20132030 (2022).","journal-title":"Sci. China Life Sci."},{"key":"1272_CR14","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat. Commun. 12, 5872 (2021).","journal-title":"Nat. Commun."},{"key":"1272_CR15","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.7150\/thno.45631","volume":"10","author":"X Le","year":"2020","unstructured":"Le, X. et al. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative\/ER stress-mediated apoptosis and pyroptosis. Theranostics 10, 9495\u20139511 (2020).","journal-title":"Theranostics"},{"key":"1272_CR16","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41388-023-02718-2","volume":"42","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer. Oncogene 42, 2126\u20132138 (2023).","journal-title":"Oncogene"},{"key":"1272_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol. Cancer 23, 148 (2024).","journal-title":"Mol. Cancer"},{"key":"1272_CR18","doi-asserted-by":"crossref","unstructured":"Jiang, H. et al. Protein semisynthesis reveals plasticity in HECT E3 ubiquitin ligase mechanisms. Nat. Chem. 16, 1894\u20131905 (2024).","DOI":"10.1038\/s41557-024-01576-z"},{"key":"1272_CR19","doi-asserted-by":"publisher","first-page":"eadi0178","DOI":"10.1126\/scitranslmed.adi0178","volume":"16","author":"S Zheng","year":"2024","unstructured":"Zheng, S. et al. Extracellular vesicle-packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models. Sci. Transl. Med. 16, eadi0178 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1272_CR20","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1021\/acsnano.4c05100","volume":"18","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Bismuth sulfide nanoflowers facilitated miR339 delivery to overcome stemness and radioresistance through ubiquitin-specific peptidase 8 in esophageal cancer. ACS Nano 18, 19232\u201319246 (2024).","journal-title":"ACS Nano"},{"key":"1272_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/path.6298","volume":"263","author":"M Brunet","year":"2024","unstructured":"Brunet, M. et al. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis. J. Pathol. 263, 466\u2013481 (2024).","journal-title":"J. Pathol."},{"key":"1272_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-024-01357-8","volume":"31","author":"J Hong","year":"2024","unstructured":"Hong, J. et al. The PRMT6\/STAT1\/ACSL1 axis promotes ferroptosis in diabetic nephropathy. Cell Death Differ. 31, 1\u201310 (2024).","journal-title":"Cell Death Differ."},{"key":"1272_CR23","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.cmet.2024.07.008","volume":"36","author":"C Mo","year":"2024","unstructured":"Mo, C. et al. Dopaminylation of endothelial TPI1 suppresses ferroptotic angiocrine signals to promote lung regeneration over fibrosis. Cell Metab. 36, 1839\u20131857.e1812 (2024).","journal-title":"Cell Metab."},{"key":"1272_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.gastro.2024.07.038","volume":"167","author":"X Cheng","year":"2024","unstructured":"Cheng, X. et al. Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response. Gastroenterology 167, 1\u201310 (2024).","journal-title":"Gastroenterology"},{"key":"1272_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab, A. et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat. Cell Biol. 26, 1\u201311 (2024).","journal-title":"Nat. Cell Biol."},{"key":"1272_CR26","doi-asserted-by":"publisher","first-page":"217000","DOI":"10.1016\/j.canlet.2024.217000","volume":"595","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. The EGR1\/miR-139\/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis. Cancer Lett. 595, 217000 (2024).","journal-title":"Cancer Lett."},{"key":"1272_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan, H. et al. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 33, 185\u2013188 (2023).","journal-title":"Trends Cell Biol."},{"key":"1272_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2023.12.038","volume":"366","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Apigenin-7-glucoside-loaded nanoparticle alleviates intestinal ischemia-reperfusion by ATF3\/SLC7A11-mediated ferroptosis. J. Control. Release 366, 182\u2013193 (2024).","journal-title":"J. Control. Release"},{"key":"1272_CR29","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41388-024-02996-4","volume":"43","author":"N Cao","year":"2024","unstructured":"Cao, N. et al. LPCAT2 inhibits colorectal cancer progression via the PRMT1\/SLC7A11 axis. Oncogene 43, 1714\u20131725 (2024).","journal-title":"Oncogene"},{"key":"1272_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41418-024-01270-0","volume":"31","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death Differ. 31, 431\u2013446 (2024).","journal-title":"Cell Death Differ."},{"key":"1272_CR31","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1021\/acs.jproteome.3c00151","volume":"22","author":"S Sardana","year":"2023","unstructured":"Sardana, S. et al. S-palmitoylation during retinoic acid-induced neuronal differentiation of SH-SY5Y neuroblastoma cells. J. Proteome Res. 22, 2421\u20132435 (2023).","journal-title":"J. Proteome Res."},{"key":"1272_CR32","first-page":"1","volume":"3","author":"H Yao","year":"2019","unstructured":"Yao, H. et al. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat. Biomed. Eng. 3, 1\u201310 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"1272_CR33","doi-asserted-by":"publisher","first-page":"e2410263","DOI":"10.1002\/advs.202410263","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. NAT10 promotes gastric cancer liver metastasis by modulation of M2 macrophage polarization and metastatic tumor cell hepatic adhesion. Adv. Sci. 12, e2410263 (2025).","journal-title":"Adv. Sci."},{"key":"1272_CR34","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1038\/s41388-024-03114-0","volume":"43","author":"X Tang","year":"2024","unstructured":"Tang, X. et al. Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis. Oncogene 43, 2635\u20132646 (2024).","journal-title":"Oncogene"},{"key":"1272_CR35","doi-asserted-by":"publisher","first-page":"216796","DOI":"10.1016\/j.canlet.2024.216796","volume":"589","author":"Z Zhao","year":"2024","unstructured":"Zhao, Z. et al. Activation of the FOXM1\/ASF1B\/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. Cancer Lett. 589, 216796 (2024).","journal-title":"Cancer Lett."},{"key":"1272_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbrc.2019.02.060","volume":"511","author":"Z Jiangqiao","year":"2019","unstructured":"Jiangqiao, Z. et al. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma. Biochem. Biophys. Res. Commun. 511, 165\u2013172 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1272_CR37","doi-asserted-by":"publisher","first-page":"731547","DOI":"10.3389\/fonc.2021.731547","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. ASF1B promotes oncogenesis in lung adenocarcinoma and other cancer types. Front. Oncol. 11, 731547 (2021).","journal-title":"Front. Oncol."},{"key":"1272_CR38","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/s41467-023-42170-0","volume":"14","author":"DW Jeong","year":"2023","unstructured":"Jeong, D. W. et al. Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat. Commun. 14, 6370 (2023).","journal-title":"Nat. Commun."},{"key":"1272_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semcancer.2021.04.002","volume":"85","author":"X Dai","year":"2022","unstructured":"Dai, X. et al. Post-translational regulations of PD-L1 and PD-1: mechanisms and opportunities for combined immunotherapy. Semin. Cancer Biol. 85, 246\u2013252 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"1272_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.freeradbiomed.2024.02.001","volume":"214","author":"L Jiang","year":"2024","unstructured":"Jiang, L. et al. Elaborate cooperation of poly(rC)-binding proteins 1\/2 and glutathione in ferroptosis induced by plasma-activated Ringer\u2019s lactate. Free Radic. Biol. Med. 214, 28\u201341 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"1272_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/mc.23533","volume":"62","author":"Y Luo","year":"2023","unstructured":"Luo, Y. et al. PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation. Mol. Carcinog. 62, 907\u2013919 (2023).","journal-title":"Mol. Carcinog."},{"key":"1272_CR42","doi-asserted-by":"publisher","first-page":"102276","DOI":"10.1016\/j.redox.2022.102276","volume":"51","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Poly(rC)-binding protein 1 represses erritinophagy-mediated ferroptosis in head and neck cancer. Redox Biol. 51, 102276 (2022).","journal-title":"Redox Biol."},{"key":"1272_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P. et al. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599\u2013620 (2021).","journal-title":"Protein Cell"},{"key":"1272_CR44","first-page":"e2410263","volume":"12","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Deubiquitylase USP52 promotes bladder cancer progression by modulating ferroptosis through stabilizing SLC7A11\/xCT. Adv. Sci. 12, e2410263 (2024).","journal-title":"Adv. Sci."},{"key":"1272_CR45","doi-asserted-by":"publisher","first-page":"e152067","DOI":"10.1172\/JCI152067","volume":"131","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J. Clin. Invest. 131, e152067 (2021).","journal-title":"J. Clin. Invest."},{"key":"1272_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J. Exp. Clin. Cancer Res. 40, 206 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1272_CR47","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.7150\/ijbs.74546","volume":"18","author":"L Shen","year":"2022","unstructured":"Shen, L. et al. PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer. Int. J. Biol. Sci. 18, 5459\u20135474 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1272_CR48","doi-asserted-by":"publisher","first-page":"216619","DOI":"10.1016\/j.canlet.2024.216619","volume":"584","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. AMPK\u03b11-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma. Cancer Lett. 584, 216619 (2024).","journal-title":"Cancer Lett."},{"key":"1272_CR49","doi-asserted-by":"publisher","first-page":"e1300","DOI":"10.1002\/ctm2.1300","volume":"13","author":"Z Shi","year":"2023","unstructured":"Shi, Z. et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib-induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin. Transl. Med. 13, e1300 (2023).","journal-title":"Clin. Transl. Med."},{"key":"1272_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molcel.2017.08.021","volume":"68","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. ASF1a promotes non-homologous end joining repair by facilitating phosphorylation of MDC1 by ATM at double-strand breaks. Mol. Cell 68, 61\u201375 (2017).","journal-title":"Mol. Cell"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01272-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01272-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01272-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:03:16Z","timestamp":1770994996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01272-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01272-w","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}